Skip to main content
. 2022 Oct 21;16:969058. doi: 10.3389/fncel.2022.969058

FIGURE 4.

FIGURE 4

Evaluation of tropomyosin receptor kinase A (TrkA) and p75NTR pathway in CHME-5 cells treated for 2 h with nerve growth factor (NGF) isoforms. Treatments: lanes 1, control; lane 2, 10 ng/ml NGF; lane 3, 10 ng/ml painless human Nerve Growth Factor (hNGFp). The following proteins were evaluated: pAKT (ser 473); tot AKT, p MEK1/2, tot MEK, IkBα, pCREB, and actin.